MoneyWorks4Me

Sun Pharmaceutical Industries informs about board meeting

25 Jan 2022 Evaluate

Sun Pharmaceutical Industries has informed that the Board of Directors of the Company, at its meeting scheduled to be held on Monday, January 31, 2022, will consider declaration of Interim Dividend on the equity shares of the Company, for the financial year 2021-22.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..